Fresenius Medical Care Earns A Value Score, Sees EPS Estimate Raised to $2.52
Fresenius Medical Care holds a Zacks Rank #3 (Hold) with a VGM Style Score of A, driven by a Value Style Score of A and a forward P/E of 9.16. Two analysts raised fiscal 2026 EPS forecasts by $0.06 to $2.52, and the stock’s average earnings surprise is +9.7%.
1. Zacks Rank and Style Scores
Fresenius Medical Care holds a Zacks Rank #3 (Hold) supported by an A-grade VGM Score, combining Value, Growth and Momentum metrics. Its Value Style Score of A reflects a forward P/E ratio of 9.16, underscoring an attractive valuation relative to industry peers.
2. Earnings Estimate Revisions
In the past 60 days, two analysts raised their fiscal 2026 EPS projections by $0.06, lifting the consensus estimate to $2.52 per share. The company’s average earnings surprise of +9.7% highlights consistent analyst optimism and potential upside catalyst.
3. Business and Market Position
Operating through Care Delivery and Care Enablement segments, Fresenius Medical Care serves over 299,000 dialysis patients worldwide. The integrated renal care model supports stable revenue streams and reinforces its appeal to value-focused investors seeking discounted healthcare exposure.